RCE1 Positive Control for STJ502759 peptide (STJ505088)

SKU:
STJ505088-5

Shipping:
Free Shipping
Current Stock:
Applications: WB
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: RCE1 Positive Control for STJ502759 is synthetically produced from the sequence and is suitable for use in western blot applications.
Formulation: Provided as 100 uL ready-to-use, in SDS-PAGE sample buffer (Laemelli's buffer) containing Tris, pH 6.8, 1 % SDS, Glycerol and Bromophenolblue blue as tracking dye. The sample is reduced by adding 2% beta mercaptoethanol. The protein concentration is
Dilution Range: WB: 1:500
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: RCE1
Gene ID: 9986
Uniprot ID: FACE2_HUMAN
Specificity: This is positive control is recommended for use in combination with RCE1 antibody STJ502759.
Tissue Specificity Ubiquitous.
Post Translational Modifications Ubiquitinated. Undergoes 'Lys-48'- and 'Lys-63'-linked ubiquitination. 'Lys-48' ubiquitination induces its degradation. Deubiquitinated by USP17L2/USP17 that cleaves 'Lys-63'-linked ubiquitin chains.
Function Proteolytically removes the C-terminal three residues of farnesylated and geranylated proteins. Seems to be able to process K-Ras, N-Ras, H-Ras, RAP1B and G-gamma-1.
Peptide Name Caax Prenyl Protease 2
Farnesylated Proteins-Converting Enzyme 2
Face-2
Prenyl Protein-Specific Endoprotease 2
Rce1 Homolog
Hrce1
Database Links Reactome: R-HSA-5689880
Reactome: R-HSA-9648002
Cellular Localisation Endoplasmic Reticulum Membrane
Multi-Pass Membrane Protein
Alternative Peptide Names Caax Prenyl Protease 2 protein
Farnesylated Proteins-Converting Enzyme 2 protein
Face-2 protein
Prenyl Protein-Specific Endoprotease 2 protein
Rce1 Homolog protein
Hrce1 protein
RCE1 protein
FACE2 protein
RCE1A protein
RCE1B protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance